Saturday, May 25, 2013 7:00:46 PM
By Joel Rosenblatt - May 25, 2013 9:14 AM PT Facebook Share Tweet
Biological warfare defense firms Siga Technologies Inc. (SIGA) and PharmAthene Inc. soared after a mixed ruling by the Delaware Supreme Court affirmed Siga’s liability over a smallpox medicine licensing agreement while setting aside a potential multibillion-dollar damages ruling for PharmAthene.
The court’s decision yesterday mirrored Delaware Chancery Judge Donald Parsons Jr.’s 2011 ruling on liability while ordering him to reconsider the amount of damages. Siga rose as much as 41 percent after the close to $5.15 before it was halted at $4.40. PharmAthene rose as much as 53 percent to $2.45 before falling back to $2.37.
PharmAthene, a developer of biological and chemical defense products based in Annapolis, Maryland, sued New York-based competitor Siga in 2006, claiming it had a licensing agreement for the medicine. PharmAthene said it should share in as much as $5 billion in potential sales, mostly from government contracts for ST-246. The antiviral drug is intended for use in case of a biological attack.
Parsons ruled in 2011 that PharmAthene was entitled to 50 percent of profit from sales of ST-246 once Siga earned a profit of $40 million. The state high court yesterday affirmed his decision that Siga is liable for breaking its contractual obligations to negotiate a licensing agreement in good faith.
Siga officials said last year that the company won a five-year U.S. government contract for 2 million doses of ST-246 in a deal that could be worth as much as $2.8 billion.
In its lawsuit, PharmAthene argued it had a claim to ST-246’s profits because it helped fund the drug’s development and Siga reneged on promises to grant a licensing agreement.
Stephen Lamb, a lawyer for Siga, and Stacey Jurchison, a spokeswoman for PharmAthene, didn’t immediately respond to phone and e-mail messages yesterday after regular business hours seeking comment on the decision.
The case is Siga Technologies v. PharmAthene, 12-00314, Delaware Supreme Court. The Chancery Court case is PharmAthene Inc. (PIP) v. Siga Technologies Inc., CA2627, Delaware Chancery Court (Wilmington).
To contact the reporter on this story: Joel Rosenblatt in San Francisco at jrosenblatt@bloomberg.net
Recent SIGA News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2024 08:07:46 PM
- SIGA Announces New Contract Awarded by U.S. Department of Defense for the Procurement of $9 Million of TPOXX® • GlobeNewswire Inc. • 08/21/2024 08:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/15/2024 11:40:18 AM
- Topline Results from PALM 007 Study of SIGA’s Tecovirimat in Treatment of Mpox Released • GlobeNewswire Inc. • 08/15/2024 11:35:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/01/2024 08:59:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 08:06:09 PM
- SIGA Reports Financial Results for Three and Six Months Ended June 30, 2024 • GlobeNewswire Inc. • 08/01/2024 08:05:00 PM
- SIGA to Host Business Update Call on August 1 Following Release of Second-Quarter 2024 Financial Results • GlobeNewswire Inc. • 07/25/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/19/2024 12:05:49 PM
- SIGA Announces U.S. Government Procurement Order of $113 Million for Oral TPOXX® • GlobeNewswire Inc. • 07/19/2024 12:00:00 PM
- SIGA Announces Agreement to Sell TPOXX® to ASEAN Member States • GlobeNewswire Inc. • 06/17/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 08:28:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 08:23:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 08:21:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 08:18:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 08:16:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 08:13:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 08:11:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 08:08:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 08:05:57 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2024 08:58:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:06:24 PM
- SIGA Reports Financial Results for Three Months Ended March 31, 2024 • GlobeNewswire Inc. • 05/07/2024 08:05:00 PM
- SIGA Technologies to Host Business Update Call on May 7 Following Release of First-Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/01/2024 09:00:00 PM
- SIGA Amends International Promotion Agreement with Meridian to Enhance International Growth Opportunities of Oral TPOXX® • GlobeNewswire Inc. • 04/01/2024 08:05:00 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM